Mafosfamide
- Level
- Commodity
- Parent
- 51112500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51112511This classification denotes a nitrogen mustard compound with the molecular formula C9H19Cl2N2O5PS2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5970HH9923, chemically known as ethanesulfonic acid, 2-(((2r,4r)-2-(bis(2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorin-4-yl)thio)-, rel- but more generally known as mafosfamide, which bears US NIH Compound Identifier 104746. European Medicines Agency schedules Mafosfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08635MIG. The term MAFOSFAMIDE is an International Non-Proprietary Name. MAFOSFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule mafosfamide under HS 29349990 and SITC 51579. As of Q4 2014, MAFOSFAMIDE remains US FDA's Preferred Term for this commodity. Mafosfamide bears US NLM identifiers UMLS ID C0065506 and NCI Concept Code C1150. SMILES: CLCCN(P1(=O)OCCC(SCCS(=O)(=O)O)N1)CCCL.
Same parent
Under 51112500 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.